02-10669. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group, Diabetes, Endocrinology and Metabolic Diseases B Subcommittee.

Date: June 18, 2002.

Open: 8 a.m. to 8:30 a.m.

Agenda: To review procedures and discuss policy.

Place: Canterbury Hotel, 780 Sutter Street, San Francisco, CA 94109.

Closed: 8:30 a.m. to adjournment.

Agenda: To review and evaluate grant applications

Place: Canterbury Hotel, 780 Sutter Street, San Francisco, CA 94109.

Contact Person: Michele L. Barnard, Scientific Review Administrator, Review Branch, DEA NIDDK, National Institutes of Health, Room 657, 6707 Democracy Boulevard, Bethesda, MD 20892. 301/594-8898.

(Catalogue of Federal Domestic Assistance Programs Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: April 23, 2002.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.